Cargando…
Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma
Background: High uptake of F18-fluorodeoxyglucose parameters for glucose metabolism is related to shorter survival in sinonasal tract cancer with various histological classifications. We investigated whether F18-fluorodeoxyglucose uptake parameters are associated with survival outcomes for patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775068/ https://www.ncbi.nlm.nih.gov/pubmed/35054313 http://dx.doi.org/10.3390/diagnostics12010146 |
_version_ | 1784636492954468352 |
---|---|
author | Suzuki, Hidenori Tamaki, Tsuneo Kodaira, Takeshi Nishio, Masami Nishikawa, Daisuke Beppu, Shintaro Terada, Hoshino Sawabe, Michi Hanai, Nobuhiro |
author_facet | Suzuki, Hidenori Tamaki, Tsuneo Kodaira, Takeshi Nishio, Masami Nishikawa, Daisuke Beppu, Shintaro Terada, Hoshino Sawabe, Michi Hanai, Nobuhiro |
author_sort | Suzuki, Hidenori |
collection | PubMed |
description | Background: High uptake of F18-fluorodeoxyglucose parameters for glucose metabolism is related to shorter survival in sinonasal tract cancer with various histological classifications. We investigated whether F18-fluorodeoxyglucose uptake parameters are associated with survival outcomes for patients with only squamous cell carcinoma (SCC) in the sinonasal tract that are treated either with surgery or nonsurgery. Methods: We retrospectively observed F18-fluorodeoxyglucose uptake parameters on positron emission tomography with computed tomography for the primary tumour of SCC in 39 patients. Log-rank test or a Cox regression model with 95% confidence interval (95%CI) and hazard ratio (HR) were used for monovariable or multivariable analysis, respectively. We determined cut-off values of the F18-fluorodeoxyglucose uptake parameters using the lowest p value for monovariable sinonasal tract cancer-specific survival analysis. Results: Monovariable analysis showed that patients with metabolic tumour volume (MTV) ≥ 21.8 had a shorter cancer-specific, disease-free and local recurrence-free survival than those with MTV < 21.8. After adjusting for age, gender, clinical stage and treatment group in the multivariable analysis, MTV (≥21.8/<21.8) was related to shorter cancer-specific (HR: 3.69, 95%CI: 1.17–12.0), disease-free (HR: 3.38, 95%CI: 1.19–9.71) and local recurrence-free (HR: 5.42, 95%CI: 1.59–20.3) survivals. Conclusions: MTV as advances in diagnostics of sinonasal tract SCC is a predictor. |
format | Online Article Text |
id | pubmed-8775068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87750682022-01-21 Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma Suzuki, Hidenori Tamaki, Tsuneo Kodaira, Takeshi Nishio, Masami Nishikawa, Daisuke Beppu, Shintaro Terada, Hoshino Sawabe, Michi Hanai, Nobuhiro Diagnostics (Basel) Article Background: High uptake of F18-fluorodeoxyglucose parameters for glucose metabolism is related to shorter survival in sinonasal tract cancer with various histological classifications. We investigated whether F18-fluorodeoxyglucose uptake parameters are associated with survival outcomes for patients with only squamous cell carcinoma (SCC) in the sinonasal tract that are treated either with surgery or nonsurgery. Methods: We retrospectively observed F18-fluorodeoxyglucose uptake parameters on positron emission tomography with computed tomography for the primary tumour of SCC in 39 patients. Log-rank test or a Cox regression model with 95% confidence interval (95%CI) and hazard ratio (HR) were used for monovariable or multivariable analysis, respectively. We determined cut-off values of the F18-fluorodeoxyglucose uptake parameters using the lowest p value for monovariable sinonasal tract cancer-specific survival analysis. Results: Monovariable analysis showed that patients with metabolic tumour volume (MTV) ≥ 21.8 had a shorter cancer-specific, disease-free and local recurrence-free survival than those with MTV < 21.8. After adjusting for age, gender, clinical stage and treatment group in the multivariable analysis, MTV (≥21.8/<21.8) was related to shorter cancer-specific (HR: 3.69, 95%CI: 1.17–12.0), disease-free (HR: 3.38, 95%CI: 1.19–9.71) and local recurrence-free (HR: 5.42, 95%CI: 1.59–20.3) survivals. Conclusions: MTV as advances in diagnostics of sinonasal tract SCC is a predictor. MDPI 2022-01-07 /pmc/articles/PMC8775068/ /pubmed/35054313 http://dx.doi.org/10.3390/diagnostics12010146 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suzuki, Hidenori Tamaki, Tsuneo Kodaira, Takeshi Nishio, Masami Nishikawa, Daisuke Beppu, Shintaro Terada, Hoshino Sawabe, Michi Hanai, Nobuhiro Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title | Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title_full | Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title_fullStr | Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title_full_unstemmed | Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title_short | Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma |
title_sort | metabolic tumour volume as a predictor of survival for sinonasal tract squamous cell carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775068/ https://www.ncbi.nlm.nih.gov/pubmed/35054313 http://dx.doi.org/10.3390/diagnostics12010146 |
work_keys_str_mv | AT suzukihidenori metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT tamakitsuneo metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT kodairatakeshi metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT nishiomasami metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT nishikawadaisuke metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT beppushintaro metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT teradahoshino metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT sawabemichi metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma AT hanainobuhiro metabolictumourvolumeasapredictorofsurvivalforsinonasaltractsquamouscellcarcinoma |